Progress in understanding hypersensitivity drug reactions: An overview

Current Opinion in Allergy and Clinical Immunology

Volumn 12, Issue 4, 2012, Pages 337-340

  Blanca, Miguel ^a   Thong, Bernard ^b  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b TAN TOCK SENG HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1 INHIBITOR; FAS LIGAND; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 13; NONSTEROID ANTIINFLAMMATORY AGENT; PERFORIN; SERUM ALBUMIN; TUMOR NECROSIS FACTOR;

ALBUMIN BLOOD LEVEL; ANAPHYLAXIS; ANTIBODY RESPONSE; CYSTIC FIBROSIS; DESENSITIZATION; DISEASE SEVERITY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; HISTAMINE RELEASE; HUMAN; INSECT STING; MAST CELL; MASTOCYTOSIS; MOLECULAR WEIGHT; PRESCRIPTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; REVIEW; SKIN TEST; STEVENS JOHNSON SYNDROME; TH2 CELL; TOXIC EPIDERMAL NECROLYSIS; UPREGULATION;

DRUG HYPERSENSITIVITY; HUMANS; IMMUNITY, CELLULAR; IMMUNOGLOBULIN E; T-LYMPHOCYTES;

EID: 84864283648     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e328355b8f5     Document Type: Review

References (45)

1. Gomez E, Blanca M, Torres MJ, Mayorga C. Immunologic evaluation of drug allergy. Allergy Asthma Immunol Res 2012 (in press).
2. Caubet JC, Eigenmann P. Diagnostic issues in pediatric drug allergy. Curr Opin Allergy Clin Immunol 2012 (to be assigned).
3. Mattheij M, de Vries E. A suspicion of antibiotic allergy in children is often incorrect. J Allergy Clin Immunol 2012; 129:583.
4. Doña I, Blanca-Lopez N, Torres MJ, et al. Hypersensitivity reactions to drugs: patterns of responses, drugs involved and temporal variation in a large serie of patients evaluated. J Investig Allergol Clin Immunol 2012 (in press).
5. Rubio M, Bousquet PJ, Gomes E, et al. Results of drug hypersensitivity evaluations in a large group of children and adults. Clin Exp Allergy 2012; 42:123-130.
6. Seitz CS, Brocker EB, Trautmann A. Diagnosis of drug hypersensitivity in children and adolescents: discrepancy between physician-based assessment and results of testing. Pediatr Allergy Immunol 2011; 22:405-410.
7. Blanca-Lopez N, Zapatero L, Alonso E, et al. Skin testing and drug provocation in the diagnosis of nonimmediate reactions to aminopenicillins in children. Allergy 2009; 64:229-233.
8. Caubet JC, Kaiser L, Lemaitre B, et al. The role of penicillin in benign skin rashes in childhood: a prospective study based on drug rechallenge. J Allergy Clin Immunol 2011; 127:218-222.
9. Padial A, Antunez C, Blanca-Lopez N, et al. Nonimmediate reactions to betalactams: diagnostic value of skin testing and drug provocation test. Clin Exp Allergy 2008; 38:822-828. (Pubitemid 351559564)
10. Blanca M, Romano A, Torres MJ, et al. Update on the evaluation of hypersensitivity reactions to betalactams. Allergy 2009; 64:183-193.
11. Torres MJ, Ariza A, Mayorga C, et al. Clavulanic acid can be the component in amoxicillin-clavulanic acid responsible for immediate hypersensitivity reactions. J Allergy Clin Immunol 2010; 125:502-505; e2.
12. Ponvert C, Perrin Y, Bados-Albiero A, et al. Allergy to betalactam antibiotics in children: results of a 20-year study based on clinical history, skin and challenge tests. Pediatr Allergy Immunol 2011; 22:411-418.
13. Romano A, Gaeta F, Valluzzi RL, et al. IgE-mediated hypersensitivity to cephalosporins: cross-reactivity and tolerability of penicillins, monobactams, and carbapenems. J Allergy Clin Immunol 2010; 126:994-999.
14. Doña I, Blanca-Lopez N, Cornejo-Garc?a JA, et al. Characteristics of subjects experiencing hypersensitivity to nonsteroidal anti-inflammatory drugs: patterns of response. Clin Exp Allergy 2011; 41:86-95.
15. Sanchez-Borges M, Capriles-Behrens E, Caballero-Fonseca F. Hypersensitivity to nonsteroidal anti-inflammatory drugs in childhood. Pediatr Allergy Immunol 2004; 15:376-380. (Pubitemid 39093497)
16. Viola M, Rumi G, Valluzzi RL, et al. Assessing potential determinants of positive provocation tests in subjects with NSAID hypersensitivity. Clin Exp Allergy 2011; 41:96-1031.
17. Mart?n-Muñoz MF, Pereira MJ, Posadas S, et al. Anaphylactic reaction to diphtheria-tetanus vaccine in a child: specific IgE/IgG determinations and cross-reactivity studies. Vaccine 2002; 20:3409-3412. (Pubitemid 35245824)
18. Mayorga C, Torres MJ, Corzo JL, et al. Immediate allergy to tetanus toxoid vaccine: determination of immunoglobulin E and immunoglobulin G antibodies to allergenic proteins. Ann Allergy Asthma Immunol 2003; 90:238-243. (Pubitemid 36231748)
19. Chang YS. Hypersensitivity reactions to Proton Pump Inhibitors. Curr Opin Allergy Clin Immunol 2012 (to be assigned).
20. Parikh N, Howden CW. The safety of drugs used in acid-related disorders and functional gastrointestinal disorders. Gastroenterol Clin North Am 2010; 39:529-542.
21. Chen J, Yuan YC, Leontiadis GI, et al. Recent safety concerns with proton pump inhibitors. J Clin Gastroenterol 2012; 46:93-114.
22. Perez-Ezquerra PR, Morillas LS, Mart?nez JJ, et al. Anaphylaxis to omeprazole. Cross-reactivity with the other proton pump inhibitors. Allergol Immunopathol (Madr) 2011; 39:54.
23. Sobrevia Elfau MT, Garces Sotillos M, Ferrer Claver?a L, et al. Study of crossreactivity between proton pump inhibitors. J Investig Allergol Clin Immunol 2010; 20:157-161.
24. Lobera T, Navarro B, Del Pozo MD, et al. Nine cases of omeprazole allergy: cross-reactivity between proton pump inhibitors. J Investig Allergol Clin Immunol 2009; 19:57-60.
25. Gamboa PM, Sanz ML, Urrutia I, et al. CD63 expression by flow cytometry in the in vitro diagnosis of allergy to omeprazole. Allergy 2003; 58:538-539. (Pubitemid 36649325)
26. Aranda A, Mayorga C, Ariza A, et al. IgE-mediated hypersensitivity reactions to methylprednisolone. Allergy 2010; 65:1376-1380.
27. Gomez E, Blanca-Lopez N, Torres MJ, et al. Immunoglobulin E-mediated immediate allergic reactions to dipyrone: value of basophil activation test in the identification of patients. Clin Exp Allergy 2009; 39:1217-1224.
28. Wagner N, Fritze D, Przybilla B, et al. Fatal anaphylactic sting reaction in a patient with mastocytosis. Int Arch Allergy Immunol 2008; 146:162-163. (Pubitemid 351685480)
29. Bonadonna P, Perbellini O, PassalacquaG, et al. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels. J Allergy Clin Immunol 2009; 123:680-686.
30. Bilo MB, Frontini F, Massaccesi C, et al. Mast cell diseases and the severity and course of intraoperative anaphylaxis. Ann Allergy Asthma Immunol 2009; 103:175-176.
31. Brockow K, Bonadonna P. Drug allergy and mast cell disease. Curr Opin Allergy Clin Immunol 2012 (to be assigned).
32. Mertes PM, Demoly P, Malinovsky JM. Hypersensitivity reactions in the anaesthesia setting/allergic reactions to anaesthetics. Curr Opin Allergy Clin Immunol 2012 (to be assigned).
33. Romano A, Mayorga C, Torres MJ, et al. Immediate allergic reactions to cephalosporins: cross-reactivity and selective responses. J Allergy Clin Immunol 2000; 106:1177-1183. (Pubitemid 32006274)
34. Antunez C, Blanca-Lopez N, Torres MJ, et al. Immediate allergic reactions to cephalosporins: evaluation of cross-reactivity with a panel of penicillins and cephalosporins. J Allergy Clin Immunol 2006; 117:404-410. (Pubitemid 43190154)
35. Whitaker P, Naisbitt D, Peckham D. Non-Immediate beta-lactam reactions in patients with cystic fibrosis. Curr Opin Allergy Clin Immunol 2012 (to be assigned).
36. Wills R, Henry R, Francis J. Antibiotic hypersensitivity reactions in cystic fibrosis. J Paediatr Child Health 1998; 34:325-329. (Pubitemid 28355381)
37. Koch C, Hjelt K, Pedersen S, et al. Retrospective clinical study of hypersensitivity reactions to aztreonam and six other beta-lactam antibiotics in cystic fibrosis patients receiving multiple treatment courses. Rev Infect Dis 1991; 13 (Suppl 7):S608-S611.
38. Pleasants R, Walker T, Samuelson W. Allergic reactions to parenteral betalactam antibiotics in patients with cystic fibrosis. Chest 1994; 106:1124-1128. (Pubitemid 24309550)
39. Torres MJ, Mayorga C, Blanca M. No immediate allergic reactions induced by drugs: pathogenesis and diagnostic tests. J Investig Allergol Clin Immunol 2009; 19:80-90.
40. Fernandez TD, Mayorga C, Torres MJ, et al. Cytokine and chemokine expression in the skin from patients with maculopapular exanthema to drugs. Allergy 2008; 63:712-719. (Pubitemid 351591846)
41. Whitaker P, Meng X, Lavergne SN, et al. Mass spectrometric characterization of circulating and functional antigens derived from piperacillin in patients with cystic fibrosis. J Immunol 2011; 187:200-211.
42. Tohyama M, Hashimoto K. Immunological mechanisms of epidermal damage in toxic epidermal necrolysis. Curr Opin Allergy Clin Immunol 2012 (to be assigned).
43. Posadas SJ, Padial A, Torres MJ, et al. Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity. J Allergy Clin Immunol 2002; 109:155-161. (Pubitemid 34112146)
44. Bellon T, Alvarez L, Mayorga C, et al. Differential gene expression in drug hypersensitivity reactions: induction of alarmins in severe bullous diseases. Br J Dermatol 2010; 162:1014-1022.
45. Morel E, Alvarez L, Cabañas R, et al. Expression of alfa defensin 1-3 in T cells from severe cutaneous drug-induced hypersensitivity reactions. Allergy 2011; 66:360-367.